KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2011 / Cilt: 41 - Sayı: 5

Subclinical hypoxia of infants with intrauterine growth retardation determined by increased serum S100B protein levels

Cüneyt TAYMAN
Hasan KAFALI
Mustafa Mansur TATLI
Uğur DİLMEN
Nurdan URAS
Ahmet KARADAĞ
Özlem KIRMEMİŞ
Cemile KOCA
Sayfa
795–800
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Measurements of S100B may be useful in the prediction of outcome in these infants.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To test the hypothesis that serum S100B levels could be useful in detecting neurological damage in infants with intrauterine growth retardation (IUGR).
📊
Temel Bulgular & Veri:S100B protein levels were measured after birth and compared between groups.
💡
Sonuç & Katkı:Measurements of S100B may be useful in the prediction of outcome in these infants.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Key words: S100B · IUGR · intrauterine growth retardation

Özet

To test the hypothesis that serum S100B levels could be useful in detecting neurological damage in infants with intrauterine growth retardation (IUGR). Materials and methods: The study group consisted of infants with IUGR and the control group consisted of age-matched healthy infants. S100B protein levels were measured after birth and compared between groups. Results: For this study, 43 infants with IUGR and 25 infants as a control group were recruited. Gender, gestational age, type of delivery, and maternal age of the groups were statistically insignificant, with the exception of the mean birth weights (2120 ± 450 g in the IUGR group and 3096 ± 570 g in the control group (P < 0.001), respectively). S100B protein levels of the IUGR infants (1.13 ± 0.54) were significantly higher than those of the control group (0.45 ± 0.13) (P < 0.001). IUGR infants treated with antenatal steroids showed lower S100B levels than IUGR infants that did not receive antenatal steroid treatments (P < 0.05). The study group infants were divided into 2 groups, for growth retardation (GR) that was asymmetric (n = 15) and symmetric (n = 28). The asymmetric and symmetric GR infants&#8217; S100B levels were 1.14 ± 0.47 pg/mL and 1.21 ± 0.34 pg/mL, respectively, and no significant differences were found between the 2 groups in terms of S100B levels (P = 0.32). Conclusion: The results of this study favor the opinion that there is an existing intrauterine hypoxia causing hypoxic brain tissue damage in IUGR infants, even when followed up with modern obstetrical screening protocols. Measurements of S100B may be useful in the prediction of outcome in these infants.

Abstract

To test the hypothesis that serum S100B levels could be useful in detecting neurological damage in infants with intrauterine growth retardation (IUGR). Materials and methods: The study group consisted of infants with IUGR and the control group consisted of age-matched healthy infants. S100B protein levels were measured after birth and compared between groups. Results: For this study, 43 infants with IUGR and 25 infants as a control group were recruited. Gender, gestational age, type of delivery, and maternal age of the groups were statistically insignificant, with the exception of the mean birth weights (2120 ± 450 g in the IUGR group and 3096 ± 570 g in the control group (P < 0.001), respectively). S100B protein levels of the IUGR infants (1.13 ± 0.54) were significantly higher than those of the control group (0.45 ± 0.13) (P < 0.001). IUGR infants treated with antenatal steroids showed lower S100B levels than IUGR infants that did not receive antenatal steroid treatments (P < 0.05). The study group infants were divided into 2 groups, for growth retardation (GR) that was asymmetric (n = 15) and symmetric (n = 28). The asymmetric and symmetric GR infants&#8217; S100B levels were 1.14 ± 0.47 pg/mL and 1.21 ± 0.34 pg/mL, respectively, and no significant differences were found between the 2 groups in terms of S100B levels (P = 0.32). Conclusion: The results of this study favor the opinion that there is an existing intrauterine hypoxia causing hypoxic brain tissue damage in IUGR infants, even when followed up with modern obstetrical screening protocols. Measurements of S100B may be useful in the prediction of outcome in these infants.

🔖

Bu Makaleye Atıf Yap

TAYMAN, C., KAFALI, H., TATLI, M. M., DİLMEN, U., URAS, N., KARADAĞ, A., KIRMEMİŞ, Ö., KOCA, C. (2022). Subclinical hypoxia of infants with intrauterine growth retardation determined by increased serum S100B protein levels. Turkish Journal of Medical Sciences, Cilt: 41 - Sayı: 5, 795–800. https://ajindex.com/articles/611461

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Rosenberg A. Th e IUGR newborn. Semin Perinatol 2008; 32: 219-24. Salihagić-Kadić A, Medić M, Jugović D, Kos M, Latin V, Kusan Jukić M et al. Fetal cerebrovascular response to chronic hypoxia - implications for the prevention of brain damage. J Matern Fetal Neonatal Med 2006; 19: 387-96.
  2. Itakura A, Kurauchi O, Morikawa S, Matsuzawa K, Mizutani S, Tomoda Y. Neonatal EEG fi ndings soon aft er birth in the intrauterine growth retarded infant. Nippon Sanka Fujinka Gakkai Zasshi 1995; 47: 109-14.
  3. Leitner Y, Fattal-Valevski A, Geva R, Eshel R, Toledano- Alhadef H, Rotstein M et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol 2007; 22: 580-87.
  4. Gazzolo D, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009; 22: 57-61. 9. Michetti F, Gazzolo D. S100B protein in biological fl uids: a tool for perinatal medicine. Clin Chem 2002; 48: 2097-104.
  5. Gazzolo D, Marinoni E, Di Iorio R, Lituania M, Marras M, Bruschettini M et al. High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage. Clin Chem 2006; 52: 819-26.
  6. Gazzolo D, Visser GH, Lituania M, Sarli R, Bruschettini M, Michetti F et al. S100B protein cord blood levels and development of fetal behavioral states: a study in normal and small-for-dates fetuses. J Matern Fetal Neonatal Med 2002; 11: 378-84.
  7. Gazzolo D, Marinoni E, di Iorio R, Lituania M, Bruschettini PL, Michetti F. Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr Res 2002; 51: 215-9.
  8. Campbell S, Th oms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynaecol 1977; 84: 165-74.
  9. Landmann E, Reiss I, Misselwitz B, Gortner L. Ponderal index for discrimination between symmetric and asymmetric growth restriction: percentiles for neonates from 30 weeks to 43 weeks of gestation. J Matern Fetal Neonatal Med 2006; 19: 157-60.
  10. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003; 60: 614-32.
  11. Giussani DA, Th akor AS, Frulio R, Gazzolo D. Acute hypoxia increases S100beta protein in association with blood fl ow redistribution away from peripheral circulations in fetal sheep. Pediatr Res 2003; 55: 1-7.
  12. Tskitishvili E, Komoto Y, Temma-Asano K, Hayashi S, Kinu